153527-31-2

Basic information

• Product Name: [1-(2,4-dinitrophenyl)-1H-imidazol-4-yl]acetic acid
• Synonyms: [1-(2,4-dinitrophenyl)-1H-imidazol-4-yl]acetic acid
• CAS NO: 153527-31-2
• Molecular Weight: 292.208
• Mol File: 153527-31-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: [1-(2,4-dinitrophenyl)-1H-imidazol-4-yl]acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: [1-(2,4-dinitrophenyl)-1H-imidazol-4-yl]acetic acid(153527-31-2)
• EPA Substance Registry System: [1-(2,4-dinitrophenyl)-1H-imidazol-4-yl]acetic acid(153527-31-2)

Safety Data

• Hazardous Substances Data: 153527-31-2(Hazardous Substances Data)

Upstream product

• 70-34-8 2,4-Dinitrofluorobenzene 
• 3251-69-2 imidazole-4-acetic acid hydrochloride 
• 645-65-8 2-(1H-imidazol-4-yl)acetic acid 

Downstream Products

• 291779-97-0 4-{N^α-[N^Im(1)-(2,4-dinitrophenyl)-1H-imidazol-4-yl]acetyl-N^Im(1)-(2,4-dinitrophenyl)-L-histidyl}aminobutan-1-ol 
• 153527-32-3 1-(2,4-dinitrophenyl)-imidazole 4-acetic acid N-hydroxysuccinimide ester 
• 153527-35-6 N-(2-{9-{(2R,4S,5R)-5-[Bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-hydroxy-tetrahydro-furan-2-yl}-6-[2-(4-nitro-phenyl)-ethoxy]-9H-purin-2-ylamino}-ethyl)-2-[1-(2,4-dinitro-phenyl)-1H-imidazol-4-yl]-acetamide 
• 153527-33-4 N-[2-(9-{(2R,4S,5R)-5-[Bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-hydroxy-tetrahydro-furan-2-yl}-6-oxo-6,9-dihydro-1H-purin-2-ylamino)-ethyl]-2-[1-(2,4-dinitro-phenyl)-1H-imidazol-4-yl]-acetamide 

Relevant articles and documents

Expansion of repertoire of modified DNAs prepared by PCR using KOD Dash DNA polymerase

Thymidine analogues bearing a variety of functional groups at the C5-position via an amino-linker arm were prepared and the substrate activity for PCR using thermophilic KOD Dash DNA polymerase was examined. The enzyme accepted the thymidine analogues bea

Synthesis of oligonucleotides containing N2-2-(imidazol-4-ylacetamido)ethyll-2′-deoxyguanosine

Synthesis of 2′-deoxyguanosine tethered through N-2 to an imidazole is described. The modified 2′-deoxyguanosine was converted to two different phosphoramidites, one with and the other without a 6-O-protecting group. The phosphoramidites were incorporated